Could diabetes-related amputations be a thing of the past? According to the results of a recent Phase 1 clinical trial now published in STEM CELLS Translational Medicine, that just could be the case as a new stem cell therapy exhibits breakthrough promise. Apparently, the study involved injecting diabetes patients suffering from non-healing diabetic foot ulcers with a cell preparation containing adult stem cells harvested from their own fat. Amazingly, the results reveal that the regenerative therapy induced regeneration of the blood vessels surrounding the DFUs, accelerating healing and no serious side effects were observed. Led by investigators out of the National Autonomous University of Nicaragua and Dr. Michael H. Carstens with Wake Forest Institute of Regenerative Medicine and Dr. Diego Correa, University of Miami, the study titled "Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year" represents an exciting potential breakthrough for diabetic patients at risk to amputation.
Study Needs Urgent Review
Worldwide, every 30 seconds a leg is amputated, with 85 percent caused by c...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).